Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study

Triple-negative breast cancer is associated with early recurrence and low survival rates. Several trials investigate the safety of a more conservative approach of axillary treatment in clinically T1-2N0 breast cancer. Triple-negative breast cancer comprises only 15 % of newly diagnosed breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: van Roozendaal, Lori M., Smit, Leonie H. M., Duijsens, Gaston H. N. M., de Vries, Bart, Siesling, Sabine, Lobbes, Marc B. I., de Boer, Maaike, de Wilt, Johannes H. W., Smidt, Marjolein L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837212/
https://www.ncbi.nlm.nih.gov/pubmed/27013474
http://dx.doi.org/10.1007/s10549-016-3757-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837212/
https://www.ncbi.nlm.nih.gov/pubmed/27013474
http://dx.doi.org/10.1007/s10549-016-3757-4

Ejemplares similares